Please assess the completion status of the following clinical trial:

Trial Title: Effects of a Supplement Enriched in Hydroxymethylbutyrate and Vitamin D on Muscle Strength in Hip Fracture

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients over 65 years of age after hip fracture surgery.~* Ability to walk before fracture.~Exclusion Criteria:~* Chronic renal failure, defined as a glomerular filtration rate less than 60 mL/min/1.73 m2, or serum creatinine of 0.9 mg/dL in women or 1.2 mg/dL in men.~* Following a diet with protein restriction.~* Need for enteral or parenteral nutrition.~* Need for medication with orexigenic or anabolic effect, or long-term corticosteroids.~* Active neoplastic disease.~* Cognitive impairment or major psychiatric disorder.~* Lack of signed informed consent.~* Any patient with inability to comply with treatment or not appropriate according to the investigator.

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Supplement with HMB and vitamin D (Type: EXPERIMENTAL): Oral administration of 440 mL (2 bottles) of nutritional supplement with HMB and vitamin D each day during 8 weeks.
- Standard nutritional supplement (Type: ACTIVE_COMPARATOR): Oral administration of 440 mL (2 bottles) of standard nutritional supplement each day during 8 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).